Glucagon-like peptide-1 mobilizes intracellular Ca2+ and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells
Aquaporin-4 (AQP4) is less strongly expressed in human astrocytic end-feet (Eidsvaag et al., 2009) and may respond differently in neurodegenerative conditions (Colombo et al., In vitro models of the BBB based on human cells have several advantages: (i) cellular environment may be easily and reproducibly controlled
The association did not replicate in UK Biobank, although the expected power for replication in this cohort was low (Supplementary Table 11 and Supplementary Information)
Recent Clinical Trial Results: EVOKE and EVOKE+ Two recent large-scale, double-blind, placebo-controlled, phase 3 trials, known as EVOKE and EVOKE+ evaluated oral semaglutide (Rybelsus) in patients with early Alzheimers disease [23]
However, some individuals may experience mild side effects, such as: Fatigue Some users report feeling tired after injections